The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of perioperative chemotherapy plus immunotherapy in localized esophageal and gastroesophageal adenocarcinoma.
 
Mariela A. Blum Murphy
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Graciela M. Nogueras Gonzalez
No Relationships to Disclose
 
Matheus Sewastjanow-Silva
No Relationships to Disclose
 
Xuemei Wang
No Relationships to Disclose
 
Wayne L. Hofstetter
No Relationships to Disclose
 
Stephen Swisher
Consulting or Advisory Role - AstraZeneca
 
Reza J. Mehran
No Relationships to Disclose
 
Boris Sepesi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Medscape
Speakers' Bureau - AstraZeneca; Peerview
Travel, Accommodations, Expenses - Peerview
 
Manoop S. Bhutani
Consulting or Advisory Role - Oncosil; Pentax Medical Devices; Starpax Medical; Xerient
 
Brian Weston
No Relationships to Disclose
 
Emmanuel Coronel
No Relationships to Disclose
 
Rebecca E Waters
Consulting or Advisory Role - Astellas Oncology
 
Jane E. Rogers
No Relationships to Disclose
 
Jackie Smith
No Relationships to Disclose
 
Larry Lyons
Employment - Genentech
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Roche
Travel, Accommodations, Expenses - Genentech
 
Norelle Reilly
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Other Relationship - Genentech
 
James C. Yao
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Chiasma; Crinetics Pharmaceuticals; Hutchison MediPharma; Ipsen
Research Funding - Advanced Accelerator Applications; Novartis
 
Jaffer A. Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Fresenius Kabi; Gilead Sciences; GRAIL; Lilly; Merck; Novartis; oncotherics; SERVIER; zymeworks
Consulting or Advisory Role - American Cancer Society; Amgen; Arcus Biosciences; Astellas Pharma; BeiGene; BeiGene; Bristol-Myers Squibb; Geneos; Gilead Sciences; Insys Therapeutics; Merck; Novartis; SERVIER; Vaccinogen
Research Funding - Amgen; Astellas Pharma (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly